Publications by authors named "John McKnight"

Claim this Profile
W
What training and support do people need to make optimal use of automated insulin delivery systems: Interview study.
Julia Lawton, Catriona J Kyle, Thomas J G Chambers, Lesley Steven, Ashton Currie, John A McKnight

Diabet Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving electrical resistivity tomography interpretation with Gray Level Co-Occurrence Matrix textural attributes.
John McKnight, Heather Bedle, Sina Saneiyan

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report.
Hafiz Javed, Arfa Ahmad, Abdul Rehman, Michael Wagner, John E McKnight

Am J Case Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.
Huan Wang, Ruth L M Cordiner, Yu Huang, Louise Donnelly, Simona Hapca, John McKnight

Diabetes Care· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in Scotland.
Stuart J McGurnaghan, Luke A K Blackbourn, Thomas M Caparrotta, Joseph Mellor, Anna Barnett, John McKnight

BMJ Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
Regina Prigge, John A McKnight, Sarah H Wild, Aveni Haynes, Timothy W Jones

Diabet Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HbA1c Is Disproportionately Higher in Women and Older People With Type 1 Diabetes Compared With Flash Glucose Monitoring Metrics of Glycemic Control.
Roland H Stimson, Anna R Dover, Shareen Forbes, Mark W J Strachan, John A McKnight

J Diabetes Sci Technol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flash monitor initiation is associated with improvements in HbA levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
Anita Jeyam, Fraser W Gibb, John A McKnight, Joseph E O'Reilly, Thomas M Caparrotta

Diabetologia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study.
Joseph E O'Reilly, Anita Jeyam, Thomas M Caparrotta, Joseph Mellor, Andreas Hohn, John A McKnight

Diabetes Care· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes.
Evgenia Foteinopoulou, Catriona A L Clarke, Rebecca J Pattenden, Stuart A Ritchie, Emily M McMurray, John A McKnight

Diabet Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Andreas Höhn, Anita Jeyam, Thomas M Caparrotta, Stuart J McGurnaghan, Joseph E O'Reilly, John A McKnight

Diabetologia· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Anita Jeyam, Fraser W Gibb, John A McKnight, Brian Kennon, Joseph E O'Reilly

Diabetologia· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.
Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J McDonald, John A McKnight

Diabetes Care· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes.
Anna R Dover, Mark W J Strachan, John A McKnight, Roland H Stimson, Scott D Mackenzie

Diabet Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.
Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J McDonald, John A McKnight

Diabetes Care· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
Stuart J McGurnaghan, Amanda Weir, Jen Bishop, Sharon Kennedy, Luke A K Blackbourn, John McKnight

Lancet Diabetes Endocrinol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.
Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J McDonald, John A McKnight

Diabetes Care· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
Thomas M Caparrotta, Luke A K Blackbourn, Stuart J McGurnaghan, John Chalmers, Robert Lindsay, John McKnight

Diabetes Care· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
Joseph E O'Reilly, Luke A K Blackbourn, Thomas M Caparrotta, Anita Jeyam, Brian Kennon, John A McKnight

Diabetologia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes.
Roland H Stimson, Anna R Dover, Stuart A Ritchie, Rohana J Wright, John A McKnight

BMJ Open Diabetes Res Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes.
Fraser W Gibb, John A McKnight, Catriona Clarke, Mark W J Strachan

Diabetologia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in Scotland: a rising tide.
Helen M Colhoun, John McKnight

Lancet Diabetes Endocrinol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
Marco Colombo, Stuart J McGurnaghan, Luke A K Blackbourn, R Neil Dalton, David Dunger, John A McKnight

Diabetologia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland.
Anita Jeyam, Stuart J McGurnaghan, Luke A K Blackbourn, John M McKnight, Fiona Green

Diabetes Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
Marco Colombo, Stuart J McGurnaghan, Samira Bell, Finlay MacKenzie, Alan W Patrick, John A McKnight

Diabetologia· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis